Silo Pharma Inc
NASDAQ:SILO
Silo Pharma Inc
Silo Pharma, Inc. engages in the development of streetwear apparel brands. The company is headquartered in Englewood Cliffs, New Jersey. The company went IPO on 2012-01-05. The firm is focused on merging traditional therapeutics with psychedelic research for people suffering from indications, including depression, post-traumatic stress disorder (PTSD), Parkinson's disease and other neurological disorders. The firm is focused on the use of psilocybin as a therapeutic. Psilocybin is considered a serotonergic hallucinogen and is an ingredient in some species of mushrooms.
Silo Pharma, Inc. engages in the development of streetwear apparel brands. The company is headquartered in Englewood Cliffs, New Jersey. The company went IPO on 2012-01-05. The firm is focused on merging traditional therapeutics with psychedelic research for people suffering from indications, including depression, post-traumatic stress disorder (PTSD), Parkinson's disease and other neurological disorders. The firm is focused on the use of psilocybin as a therapeutic. Psilocybin is considered a serotonergic hallucinogen and is an ingredient in some species of mushrooms.